SIGNIFOR LAR

recordati rare diseases canada inc🇨🇦 Health Canada

Approval Id: ed850c557b0fe5dc
Drug Approval Canada Name: SIGNIFOR LAR
Product Name: SIGNIFOR LAR
Status: Marketed
Status Date: 2020-05-21
Original Market Date: 2019-05-30
Din: 02480425
Drug Class: Human
Dosage Form: Powder For Suspension, Sustained-Release , Kit
Route Of Administration: Intramuscular
Schedule: Prescription
Ahfs: 68:29.04
Atc Original: H01CB05 PASIREOTIDE
Atc Name: h 01 cb 05
Aig Number: 0154790007
Company Name: recordati rare diseases canada inc
Company Address: 3080 Yonge Street, Suite 6060, Toronto, Ontario, Canada, M4N 3N1

PASIREOTIDE (PASIREOTIDE PAMOATE)

10 MG / VIAL

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

ed850c557b0fe5dc

Type

Standard